Tonix Pharmaceuticals
TNXP
#8340
Rank
โ‚น20.65 B
Marketcap
โ‚น1,754
Share price
-1.57%
Change (1 day)
3.34%
Change (1 year)

Earnings for Tonix Pharmaceuticals (TNXP)

Earnings in 2025 (TTM): -โ‚น8.33 Billion

According to Tonix Pharmaceuticals's latest financial reports the company's current earnings are โ‚น10.29 Million. In 2024 the company made an earning of -โ‚น6.79 Billion, an increase over its 2023 earnings that were of -โ‚น10.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Tonix Pharmaceuticals from 2008 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น8.33 Billion22.69%
2024 -โ‚น6.79 Billion-36.5%
2023 -โ‚น10.69 Billion5.61%
2022 -โ‚น10.12 Billion21.43%
2021 -โ‚น8.33 Billion82.76%
2020 -โ‚น4.56 Billion75.22%
2019 -โ‚น2.61 Billion9.52%
2018 -โ‚น2.38 Billion23.63%
2017 -โ‚น1.93 Billion-45.36%
2016 -โ‚น3.52 Billion-19.09%
2015 -โ‚น4.35 Billion74.15%
2014 -โ‚น2.5 Billion153.99%
2013 -โ‚น0.99 Billion
2011 -โ‚น0.48 Billion29538.74%
2010 -โ‚น1.6 Million-42.58%
2009 -โ‚น2.79 Million46.05%
2008 -โ‚น1.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aerie Pharmaceuticals
AERI
-โ‚น2.1 Billion-75.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
โ‚น3.21 B-137.16%๐Ÿ‡บ๐Ÿ‡ธ USA